A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

NCT00887965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Bone Mass
Low Bone Mineral Density
Osteoporosis
Postmenopausal Osteoporosis

Interventions

DRUG: Previous denosumab

Sponsor

Amgen